Tokyo Joe's Cafe / Anything goes Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Charles J who wrote (4120)	4/13/1998 3:23:00 PM
From: Charles J	Read Replies (2) of 34592

Dakin Securities Starts Coverage of SciClone With a 'Buy' Recommendation SAN FRANCISCO, April 13 /PRNewswire/ -- Dakin Securities analyst Jim McCamant initiated coverage of SciClone Pharmaceuticals (Nasdaq: SCLN - news) with a ''buy'' recommendation. Mr. McCamant set an 18-month price target of $10 on the stock, which closed Wednesday at $3.375. He cited growing sales of SciClone's lead hepatitis product, ZADAXIN(R) thymosin alpha 1, its partnership in Japan with Schering-Plough [NYSE:SGP - news] K.K., the company's lead cystic fibrosis product, CPX, and stronger management for the recommendation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next